Clinical trialNCT00857623CompletedPhase 2Interventional

Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy

SponsorAstraZenecaEnrollment127Diabetic NeuropathyPain

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to investigate if AZD2066 can relieve the pain arising from painful diabetic neuropathy compared to placebo.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Biljana Lilja
AstraZeneca R&D Södertälje151 85 Södertälje, Sweden
Study Director
clinicaltrials.gov ↗
Charles E Argoff, MD
Albany Medical , NY 12208, USA
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Reserach Site
Bella Vista, Arkansas, United States
Research Site
National City, California, United States
Research Site
Walnut Creek, California, United States
Research Site
Clearwater, Florida, United States
Research Site
DeLand, Florida, United States
Research Site
Lauderdale Lakes, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Pembroke Pines, Florida, United States
Research Site
Madisonville, Kentucky, United States
Research Site
Owing Mills, Maryland, United States
Research Site
Bingham Farms, Michigan, United States
Research Site
Willingboro, New Jersey, United States
Reasearch Site
Albany, New York, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Indiana, Pennsylvania, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Houston, Texas, United States
Research Site
San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AZD2066Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Feb 2009
Primary completion: 31 Aug 2009
Completion: 31 Aug 2009
Last update posted: 12 Nov 2012
Registered enrollment: 127
Registry id: NCT00857623

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.